Complete

Switching off DNA repair in cancer cells

Cancer types:

General cancer research

Project period:

Research institute:

Erasmus MC

Award amount:

£228,940.04

Location:

Netherlands

Researcher Dr Maria Tresini

Dr Maria Tresini aims to study an innovative way to switch off DNA repair mechanisms in cancer cells so that they can't fix their damaged DNA, causing them to die.

Meet the scientist

Dr Maria Tresini is a senior researcher in the group of Professor Wim Vermeulen at the Erasmus MC in Rotterdam. Her lab's research tries to unravel mechanisms of DNA repair, including its implications in cancer.

The science

Dr Tresini's lab recently discovered a whole new molecular mechanism that cells have in their repertoire for DNA repair and now want to understand exactly how this mechanism works to see if it can be exploited for cancer therapy. 

The DNA in your cells is subjected all the time to damage that can lead to genetic mutations that cause cancer. In fact, research suggests that the DNA in each of your cells becomes damaged 20,000 times a day. It's a good thing that our cells come equipped with multiple defense mechanisms that detect damaged DNA and repair it. But these repair mechanisms are also responsible for keeping cancer cells alive when they suffer DNA damage, including damage caused by chemotherapeutic drugs. 

Dr Tresini is focusing on something called "R-loops" - molecular structures that occur naturally when DNA becomes damaged. These R-loops are intriguing because they activate the DNA repair process in cells but at the same time make the DNA molecule unstable and more susceptible to damage. By understanding exactly how R-loops activate DNA repair it will be possible to identify ways to block the process with drugs. This could lead to a build-up of DNA damage in cancer cells that ultimately causes the cell to die. 

Related projects

Andres Hidalgo Headshot

Active Spain

Lung cancer

How do cancer cells modify white blood cells to help tumours grow?

Researchers want to help immunotherapy work for more cancer patients by understanding how cancers hijack our immune system and preventing this happening 

Researcher: Dr Andrés Hidalgo

Understanding how cancer cells modify white blood cells to help tumours grow
Andrew Beekman and Team

Active United Kingdom

General cancer research

Can we stop cancer becoming resistant to chemotherapy?

Chemotherapy can sometimes stop working, so this project is hoping to better understand why and find ways to give more, better options to cancer patients.

Researcher: Dr Andrew Beekman

Stopping cancer becoming resistant to chemotherapy
Tim Elliott and Team

Active United Kingdom

General cancer research

Can we predict which patients will respond to immunotherapy?

This project hopes to open up exciting possibilities for personalised cancer treatment by finding how to predict which patients will respond best to treatment.

Researcher: Professor Tim Elliott

Finding ways to predict which patients will respond to immunotherapy
Share this page